The wide variety of disease associations reported at the TNF locus raises the question of how much variation exists
Introduction
TNF, the gene encoding tumour necrosis factor (TNF), resides in the central part (class III region) of the major histocompatibility complex (MHC) surrounded by a large number of other immunological genes. 1 Many disease associations have been reported with HLA alleles that are in linkage disequilibrium with TNF and in recent years there have been growing reports of disease linkage and association with microsatellite polymorphisms and single nucleotide polymorphisms close to the TNF gene itself. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] A precise description of the nucleotide diversity of this region is therefore fundamental to investigations of genetic susceptibility to infectious and inflammatory disease.
As well as serving as a genetic marker for the surrounding gene region, TNF polymorphisms may be of intrinsic functional relevance. TNF is a key mediator of the inflammatory response and is critical for host defence against a wide variety of pathogenic microbes. The dual role of TNF, acting as an agent of both innate immunity and inflammatory pathology, poses a considerable challenge for gene regulation. When exposed to a serious infection, the survival of the host depends on an adequate but not excessive level of TNF production. This optimal response is likely to vary for different infectious diseases, resulting in conflicting evolutionary pressures that might be expected to generate phenotypic diversity in TNF regulation. There is strong evidence that individuals vary in their level of TNF responsiveness to standard stimuli such as bacterial lipopolysaccharide, and that this has a significant heritable component. 12 Many papers have been published on the relationship between TNF polymorphisms and levels of TNF production, based on various human investigations and experimental models of gene regulation, but there is currently little consensus concerning whether any specific polymorphism is truly functional and, if so, how it operates (reviewed in Knight and Kwiatkowski 8 ). These observations raise the question of exactly how much nucleotide diversity exists at the TNF locus within a single population. Considering the large body of literature on disease associations with human TNF polymorphisms, there is a surprising lack of data to address this topic. Although eight polymorphisms are known to exist in the 5Ј flanking region, we are not aware of any systematic analysis of the level of nucleotide diversity throughout the coding, intronic and flanking regions. African populations are typically more diverse than Caucasian or Asian populations, 13 and the Gambian TNF locus is of particular interest because of the various TNF and MHC associations that have been observed with susceptibility to malaria and chlamydial infection in this population. 2, [5] [6] [7] 14 We therefore sequenced the entire TNF gene in 36 healthy residents of a single West African village. The total sequence under investigation was 4393 nt, extending from −1389 nt 5Ј of the transcription start site to +3004 nt 3Ј of the polyadenylation site. 
Results
Figure 1 depicts the polymorphisms identified by sequencing 72 Gambian chromosomes, and Table 1 describes the primer pairs used to genotype them. All locations refer to the transcription start site of the TNF gene as identified on Genbank accession no. M16441:
15 thus we refer to nucleotide 4095 on that sequence as +1, and nucleotide 4094 as −1.
All polymorphisms found by sequencing were heterozygous and were confirmed by sequencing in the reverse direction. The polymorphisms at −1031, −863, −857, −376, −308, −244 and −238 nt have been previously described. In this sample we did not detect the polymorphisms at −575 −163, +70 and +488 nt reported by other investigators in different populations. The polymorphisms at −1073, +467, +851, +943 and +1304 nt are novel.
The 12 polymorphisms detected by sequencing represent an overall frequency of 1 per 338 nucleotides. Eight were located in the promoter region, defined here as the 1256 nt sequence extending from the TNF transcriptional start site to the polyadenylation site of the LTa gene (1 per 157 nucleotides). Four polymorphisms were found in the three introns which comprise 1094 bases (1 per 273 nucleotides). No polymorphisms were found with four Table 1 Consensus primer sequences were located as follows: for SNPs −1077 to −863, consensus primer at −637 nt; for SNP −857, consensus primer at −1129; for SNPs −376 to −244, consensus primer at −2; for SNP −238, consensus primer at −637; for SNPs +467 and +488, consensus primer at +820 con; for SNPs +846 and +938, consensus primer +1274; for SNP +1299, consensus primer at +1016 con sense. All reactions included the positive control primers '63' and '64' which amplify a conserved 796 bp segment of exon 3 of the HLA-DRB1 gene For comparison of nucleotide diversity with other gene regions, we used the normalised number of variant sites as employed by Cargill et al:
where K is the observed number of variant sites (12), L is the total sequence length (4393 nt) and n is the number of chromosomes sequenced (72). The respective values are: 5.64 × 10 −4 for the whole of the region; 0 for the coding region; 7.05 × 10 −4 for the non-coding region overall; 7.54 × 10 −4 for the introns; and 13.14 × 10 −4 for the 5Ј flanking region.
To obtain a more accurate estimate of allele frequencies in this population, a sequence specific oligonucleotide PCR method was used to determine genotypes for an independent sample of 424 unrelated healthy Gambian adults. The results are shown in Table 2 . All alleles detected by sequencing were found by genotyping in this separate group of individuals, with the exception of the TNF+943 polymorphism which was detected by genotyp- ing only in the individual who was originally found to have this polymorphism by sequencing. All allele frequencies were consistent with Hardy-Weinberg equilibrium. Allele frequencies for the same polymorphisms were determined in 121 unrelated healthy Malawian adults. All of the Gambian polymorphisms were also found in Malawi apart from the rare TNF+943A allele. However eight of the polymorphisms showed a significant difference in allele frequency between the two populations when analysed by chi-squared test. In particular, the −1031C allele and the −863A allele were approximately double the frequency in Malawi compared to that in The Gambia (25% vs 14% and 14% vs 6% respectively, P Ͻ 0.0001 for both comparisons). To quantify the effect of population substructure we calculated Wright's fixation index for each of the variable sites, comparing the level of heterozygosity observed within each of the two subpopulations to that observed in the total data set. 16 This gave values of F ST ranging from zero to 0.016, with an average of 0.007 across all 12 polymorphisms.
From these genotypic data it is not possible to determine exact values for linkage disequilibrium, but an impression of strongly linked alleles may be gained by simple pairwise comparison of individual loci. This is illustrated in Table 3 , which gives the odds ratio of carrying the rare allele (in either homozygous or heterozygous state) at locus 1 if an individual carries the rare allele (in either homozygous or heterozygous state) at locus 2. In the table, the shaded cells highlight those pairwise comparisons which give P Ͻ 0.01 by chi-squared test. A very similar pattern of association emerges in both Gambian and Malawian populations. The TNF−1031C, −863A, −376A, −238A, +851G, and +1304G alleles appear to be linked to each other in both populations. Additionally, TNF−244A appears to be linked to TNF−376A, −238A, +851G and +1304G in Malawi, and TNF−1073T appears linked to −857T in The Gambia. 17 among 75 genes. In both of these studies, the various ethnic groups from around the world were sampled. Thus the level of nucleotide diversity at the TNF locus within a single African village is comparable to the global value for human autosomal genes across different continents. These data do not allow us to draw firm conclusions about the relative nucleotide diversity of TNF compared to other loci, or about the overall level of genetic diversity in Sukuta compared to other communities, and systematic surveys of multiple gene loci in other well-defined communities are needed to address these issues. However an emerging body of data suggests that many of the common variable sites in the human genome may be found within a single African community, unless it happens to derive from a small number of founders and is highly inbred, and our present findings would be highly consistent with this notion.
Genes and Immunity
In this Gambian study population, we found a significantly higher frequency of polymorphic sites in the TNF promoter region compared to the TNF coding region (8 per 1256 nt vs 0 per 873 nt, P = 0.01). The corresponding values of are 13.1 × 10 −4 for the promoter region and 0 for the coding region, which is a wider difference than observed in most other gene regions: Cargill et al 13 report average values of 5.43 × 10 −4 and 5.30 × 10 −4 for noncoding and coding regions respectively. However approximately 10% of genes studied by these authors had a nucleotide diversity of у14 × 10 −4 in the non-coding region, while over 5% had no observed nucleotide diversity in the coding region. Taken together, it would seem that the TNF promoter region may be somewhat more variable and the coding region rather less variable than average, but both are within the range of values observed elsewhere in the genome.
All of the polymorphisms that we identified in the Gambian population were also found in Malawians, with the exception of a rare TNF+943A allele which was present in only one of the 576 individuals that we analysed. Malawi and The Gambia are geographically remote and their populations are known to be genetically different, 18 so it is not surprising that eight of the 12 TNF polymorphisms are at significantly different frequency in the two populations. However the level of population differentiation was relatively low when assessed by A growing number of disease associations have been reported for polymorphisms in the TNF promoter region. These include associations between infectious diseases and the TNF−308A allele, the TNF−238A allele and the TNF−376A allele. [2] [3] [4] [5] [6] [7] [8] To give a few examples of associations with non-infectious diseases, asthma has been associated with the TNF−308A allele, 9 multiple sclerosis with the TNF−376A allele, 10 rheumatoid joint damage with TNF−238G homozygotes, and Crohn's disease with the TNF−1031C allele. 11, 20 There has been some debate as to the functional significance of these associations: for example, as the TNF−308A allele has been reported to increase transcriptional activation in some experimental systems 21, 22 but not others. 23, 24 We have found that the TNF−376A allele acts to recruit the transcription factor OCT-1 to this part of the TNF promoter region 7 and this appears to be associated with a modest increase in basal gene expression in the human monocyte line MonoMac6. Allele-specific binding of OCT-1 has also been observed to the TNF-857A allele. 25 We have recently noted that the TNF−863A allele acts to reduce the binding of NF-B p50/p50, with little effect on p65/p50 binding, to this part of the TNF promoter region. 26 The effect appears to be to increase inducible TNF expression in primary human monocytes: this is consistent with observations by some investigators 27 but not others. 28, 29 It remains to be determined whether these different observations are true inconsistencies, or simply reflect the true functional heterogeneity of varied cell types under different conditions of stimulation.
The uncertain state of the functional evidence means that, if the above disease associations are replicated in independent studies, investigators must seriously consider the possibility that they relate to functional polymorphisms outside the TNF promoter region. In the case of disease associations within Caucasian populations, the true effect might turn out to map to a distant part of the MHC because of the strong linkage disequilibrium that exists across this region in Caucasians. The main import of the present study is to show that, at least in Africans, it is unlikely that the disease associations with TNF promoter polymorphisms can be ascribed to functional variation elsewhere in the TNF gene, except perhaps to two new intronic polymorphisms that we have identified at +851 and +1304 nt, that have allele frequencies as high as 17% in the Malawian population. We are currently carrying out a family analysis of polymorphisms of TNF and adjacent genes, with the goal of determining the precise extent of linkage disequilibrium at the TNF locus in Africans, and of building a detailed haplotypic map that will allow disease associations at this locus to be analysed with greater confidence.
Methods

Subjects
To screen for novel polymorphisms, blood samples were obtained from 36 healthy individuals aged 2 to 44 years, all residents of the peri-urban village of Sukuta in the Western division of The Gambia. A sample size of 36 individuals, ie 72 chromosomes, gives 95% probability of detecting an allele of у4% frequency. To estimate allele frequencies, blood samples were obtained from 424 unrelated healthy Gambian adults and 121 unrelated healthy Malawian adults. All subjects gave informed consent and the study was approved by the Gambia Govern- 
Sequencing
The first round of PCR amplification used genomic DNA (100 ng), oligonucleotide primers (0.5 M), dNTPs (0.8 mM), MgCl 2 (2.5 or 3.75 mM) and AmpliTaq Gold (1.25 U; Perkin Elmer, CA, USA) in 20l PCR buffer (Perkin Elmer). Primer pairs were: −1389 (5Ј AGG CTG ACC AAG AGA GAA AG 3Ј) and −484 (5Ј TTG AGT CCT GAG GCC TGT GT 3Ј); −952 (5Ј GTT ACA GGA GAC CTC TGG GG 3Ј) and +125 (5Ј GGA AGA GAA CCT GCC TGG C 3Ј); −88 (5Ј AGG AAG TTT TCC GCT GGT TG 3Ј) and +1565 (5Ј TCA GCT TGA GGG TTT GCT GG 3Ј); +1398 (5Ј ATA CTC AGA ACG TCA TGG CC 3Ј) and +3004 (5Ј GAG TTG GAA ATT CCC ATG CC 3Ј). An MJ Tetrad was programmed as follows: 95°C for 12 minutes; followed by 35 cycles of 94°C for 30 s, 58°C for 45 s and 70°C for 1 min; finishing with 10 min at 72°C before holding at 15°C.
The second round of PCR amplification used firstround PCR product diluted 1:10 in distilled water (1 l), primers (0.5 M), dNTPs (0.8 mM), MgCl 2 (3 mM) and AmpliTaq Gold (1.25 U; Perkin Elmer) in 30 l PCR buffer (Perkin Elmer). Primer pairs were: −1389 (as above but with the M13-21 sequence added at the 5Ј end) and −900 (5Ј M13REV GAC ATT CTC CTA CCC ATT GC 3Ј); −952 (−21M13 5Ј GTT ACA GGA GAC CTC TGG GG 3Ј) and −484 (as above but with the M13REV sequence added at the 5Ј end); −352 (−21M13 5Ј TCC CCA AAA GAA ATG GAG GC 3Ј) and +125 (as above but with the M13REV sequence added at the 5Ј end); −562 (−21M13 5Ј TTT CCT GAG GCC TCA AGC CT 3Ј) and −188 (M13REV 5Ј GTT GGG GAC ACA CAA GCA TC 3Ј); −88 (−21M13 5Ј AGG AAG TTT TCC GCT GGT TG 3Ј) and +522 (M13REV 5Ј TCT CTT GCG TCT CCA TTT CC 3Ј); +279 (−21M13 5Ј TCT TCT CCT TCC TGA TCG TG 3Ј) and +846 (M13REV 5Ј TGT GTA TTC ACC TTC CAG GC 3Ј); +773 (−21M13 5Ј AAG AAG ATA GGG TGT CTG GC 3Ј) and +1329 (M13REV 5Ј AAG TTC TGC CTA CCA TCA GC 3Ј); +1239 (−21M13 5Ј CAT GTT GTA GGT AAG AGC TC 3Ј) and +1565 (M13REV 5Ј TCA GCT TGA GGG TTT GCT GG 3Ј); +1398 (−21M13 5Ј ATA CTC AGA ACG TCA TGG CC 3Ј) and +1769 (M13REV 5Ј ACC TTG GTC TGG TAG GAG AC 3Ј); +1661 (−21M13 5Ј TGT ACC TCA TCT ACT CCC AG 3Ј) and +2240 (M13REV 5Ј TCA GGG ATC AAA GCT GTA GG 3Ј); +2137 (−21M13 5Ј TGG GAT TCA GGA ATG TGT GG 3Ј) and +2676 (M13REV 5Ј CAG TTG GTC ACC AAA TCA GC 3Ј); +2482 (−21M13 5Ј ATT TGG GAG ACC GGG GTA TC 3Ј) and +3004 (M13REV 5Ј GAG TTG GAA ATT CCC ATG CC 3Ј). An MJ Tetrad was programmed as follows: 95°C for 12 min; followed by 5 cycles of 94°C for 30 s, 57°C for 30 s and 72°C for 45 s; then 30 cycles of 94°C for 1 min, 72°C for 1 min; finishing with 10 min at 72°C before holding at 15°C.
DNA sequencing was performed on an ABI377 automated sequencer using M13 Dye primer and M13 Big dye primer sequencing kits (Perkin Elmer) and analysed using 'Factura' and 'Sequence Navigator'.
Genotyping
The amplification refractory mutation system (ARMS) method was used to genotype the polymorphisms identified at the previous stage of analysis. Primer sequences are given in 
